JONATHAN SLONIN
CIK 1875723 · Chief Medical Officer · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.03M
Companies
1
Total Filings
21
Lifetime Open-Market Net
-$557.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Chief Medical Officer | 218,912 | $22.99 | $5.03M | -$557.4K | 21 | 2026-06-05 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-02 | PCRX | Mixed | −1,250 | -$25.3K | EDGAR |
| 2024-07-03 | PCRX | Mixed | −3,312 | -$95.5K | EDGAR |
| 2024-06-13 | PCRX | Mixed | +49,288 | -$143.2K | EDGAR |
| 2024-06-05 | PCRX | Tax (F) | −1,615 | -$49.9K | EDGAR |
| 2024-01-04 | PCRX | Grant (A) | +5,000 | $0 | EDGAR |
| 2023-06-07 | PCRX | Sell (S) | −961 | -$36.9K | EDGAR |
| 2022-08-05 | PCRX | Sell (S) | −308 | -$17.2K | EDGAR |
| 2022-07-07 | PCRX | Sell (S) | −924 | -$52.8K | EDGAR |
| 2022-06-08 | PCRX | Mixed | +9,538 | -$22.2K | EDGAR |
| 2022-05-25 | PCRX | Exer (M) | +2,000 | $104.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.